A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
CME e-Learning Bookmark and Share

VTE Prophylaxis

 
Patients with cancer, particularly those undergoing active treatment, frequently experience thromboembolic events. Despite the availability of many guidelines for VTE prophylaxis data demonstrate that there is a discordance between guidelines and practice. In point of fact, VTE is a leading cause of morbidity in patients with cancer.
 
To support our staff in the furtherance of excellent treatment provided by City of Hope, the Department of Continuing Medical Education will release an accredited series of educational interventions the focus of which will be the prevention and decrease of Venous Thromboembolic Events.
 
This series has been made possible by support from the Unihealth Foundation.
 
On the Go
Hear what experts have to say about Venous Thromboembolic Events. The following can be completed in 20 minutes or less.

More Time

Receive Credit
To receive AMA PRA Category 1 Credit(s)tm you must:
  1. Register for each individual program
  2. View course materials
  3. Pass each post test with 70% or better
  4. Complete the activity evaluation
If you have any questions regarding credits, please contact the Department of Continuing Medical Education at : 626-256-4673 ext 65622 or cme@coh.org.
 

How the Experts Treat Kidney Cancer

Release date: November 22, 2011
Estimated time to complete activity: 1.25 hours

To obtain CME credit: 
 
  • Complete the evaluation form
  • Submit to CME department via
    • Fax - 626-301-8939 or
    • Email - cme@coh.org or
    • Standard mail - 1500 E. Duarte Rd., Building 94, Duarte, CA 91010
 
  • Questions:626-256-4673, ext. 65622
 
Additional Resources:

Reading List

In the US, renal cell cancer (RCC) accounts for about 3% of all adult cancers. NCI data indicate that an estimated 58,000 new cases of kidney cancer were diagnosed in 2010, and approximately 13,000 Americans died of the disease. Surgery to remove the affected kidney is the most common initial treatment for all stages of kidney cancer. However, regionally advanced or metastatic cases account for approximately half of all new cases. Historically survival rates for these patient populations have been about 20%. This poor prognosis combined with modest efficacy and high toxicity associated with currently available therapies for RCC has necessitated and resulted in the development of newer targeted therapies in order to improve outcome in these patient groups. This activity has been designed to provide the health care professional with the most current clinical and investigative data pertaining to new less invasive surgical techniques for the primary management of RCC and the expanding role of emerging multi-targeted therapies for patients with regionally advanced or metastatic RCC.

Upon successful completion of this activity, the learner should be better able to:
  • Review "traditional" and less invasive surgical techniques for the management of kidney cancer
  • Examine how new multi-targeted therapies beneficially impact the management of metastatic kidney cancer
  • Discuss current therapeutic approaches to the treatment of metastatic kidney cancer
  • Describe the multidisciplinary treatment paradigm for the treatment of kidney cancer

 

This activity has been designed to meet the needs of medical oncologists, urologists, internists and allied health care providers who treat patients with kidney cancer.
 

City of Hope is accredited by the Accreditation Council for Continuing Medical education to provide continuing medical education for physicians.
City of Hope designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The following may apply CME Category 1 credit for license renewal:
 
  • Registered Nurses: Nurses may report up to 1.25 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). CME may be noted on the license renewal application in lieu of a BRN provider number.
  • Physician’s Assistants:The National Commission on certification of Physicians Assistants states that AMA accredited Category 1 courses are acceptable fro CME requirements for recertification.
  •  
  • To receive CME credit, it is necessary to complete the post test & evaluation form. For more information,please click here.
  •  
  • City of Hope has implemented policies and procedures to be in strict compliance with current ACCME Standards of Commercial Support requiring disclosure and resolution conflicts of interest.

 

Faculty Disclosure:
As part of these new commercial guidelines, we are required to disclose if Faculty , Presenters, Authors, Planners, CME Committee Members, Course Directors and / or Moderators have any real or apparent vested commercial interest(s) in both those companies whose products may be discussed/described during the course of the activity and in those companies who may be acting as commercial supporters of the activity.

Disclosure of Off-Label Use:
This activity may contain discussion of published and/or investigational uses of agents that are not approved/indicated by the US Food and Drug Administration (FDA).

 
 

CME e-Learning

VTE Prophylaxis

VTE Prophylaxis

 
Patients with cancer, particularly those undergoing active treatment, frequently experience thromboembolic events. Despite the availability of many guidelines for VTE prophylaxis data demonstrate that there is a discordance between guidelines and practice. In point of fact, VTE is a leading cause of morbidity in patients with cancer.
 
To support our staff in the furtherance of excellent treatment provided by City of Hope, the Department of Continuing Medical Education will release an accredited series of educational interventions the focus of which will be the prevention and decrease of Venous Thromboembolic Events.
 
This series has been made possible by support from the Unihealth Foundation.
 
On the Go
Hear what experts have to say about Venous Thromboembolic Events. The following can be completed in 20 minutes or less.

More Time

Receive Credit
To receive AMA PRA Category 1 Credit(s)tm you must:
  1. Register for each individual program
  2. View course materials
  3. Pass each post test with 70% or better
  4. Complete the activity evaluation
If you have any questions regarding credits, please contact the Department of Continuing Medical Education at : 626-256-4673 ext 65622 or cme@coh.org.
 

How the Experts Treat Kidney Cancer

How the Experts Treat Kidney Cancer

Release date: November 22, 2011
Estimated time to complete activity: 1.25 hours

To obtain CME credit: 
 
  • Complete the evaluation form
  • Submit to CME department via
    • Fax - 626-301-8939 or
    • Email - cme@coh.org or
    • Standard mail - 1500 E. Duarte Rd., Building 94, Duarte, CA 91010
 
  • Questions:626-256-4673, ext. 65622
 
Additional Resources:

Reading List

In the US, renal cell cancer (RCC) accounts for about 3% of all adult cancers. NCI data indicate that an estimated 58,000 new cases of kidney cancer were diagnosed in 2010, and approximately 13,000 Americans died of the disease. Surgery to remove the affected kidney is the most common initial treatment for all stages of kidney cancer. However, regionally advanced or metastatic cases account for approximately half of all new cases. Historically survival rates for these patient populations have been about 20%. This poor prognosis combined with modest efficacy and high toxicity associated with currently available therapies for RCC has necessitated and resulted in the development of newer targeted therapies in order to improve outcome in these patient groups. This activity has been designed to provide the health care professional with the most current clinical and investigative data pertaining to new less invasive surgical techniques for the primary management of RCC and the expanding role of emerging multi-targeted therapies for patients with regionally advanced or metastatic RCC.

Upon successful completion of this activity, the learner should be better able to:
  • Review "traditional" and less invasive surgical techniques for the management of kidney cancer
  • Examine how new multi-targeted therapies beneficially impact the management of metastatic kidney cancer
  • Discuss current therapeutic approaches to the treatment of metastatic kidney cancer
  • Describe the multidisciplinary treatment paradigm for the treatment of kidney cancer

 

This activity has been designed to meet the needs of medical oncologists, urologists, internists and allied health care providers who treat patients with kidney cancer.
 

City of Hope is accredited by the Accreditation Council for Continuing Medical education to provide continuing medical education for physicians.
City of Hope designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The following may apply CME Category 1 credit for license renewal:
 
  • Registered Nurses: Nurses may report up to 1.25 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). CME may be noted on the license renewal application in lieu of a BRN provider number.
  • Physician’s Assistants:The National Commission on certification of Physicians Assistants states that AMA accredited Category 1 courses are acceptable fro CME requirements for recertification.
  •  
  • To receive CME credit, it is necessary to complete the post test & evaluation form. For more information,please click here.
  •  
  • City of Hope has implemented policies and procedures to be in strict compliance with current ACCME Standards of Commercial Support requiring disclosure and resolution conflicts of interest.

 

Faculty Disclosure:
As part of these new commercial guidelines, we are required to disclose if Faculty , Presenters, Authors, Planners, CME Committee Members, Course Directors and / or Moderators have any real or apparent vested commercial interest(s) in both those companies whose products may be discussed/described during the course of the activity and in those companies who may be acting as commercial supporters of the activity.

Disclosure of Off-Label Use:
This activity may contain discussion of published and/or investigational uses of agents that are not approved/indicated by the US Food and Drug Administration (FDA).

 
 
Education and Training
As one of only a select few National Cancer Institute-designated Comprehensive Cancer Centers in the country, City of Hope integrates all aspects of cancer research, treatment and education. We offer a range of programs serving students, post-doctoral trainees, health and medical professionals.

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Local and national conferences, in-depth educational training and a certification program provide both current and aspiring health professionals opportunities to further their knowledge in their fields of interest.
 
 
City of Hope offers a range of programs and services, such as Graduate Medical Education & Clinical Training, that serve students, post-doctoral trainees, medical professionals and staff.
The goal of the Postdoctoral Training Office is to ensure the postdoctoral experience at City of Hope is rewarding and meaningful to all participants.
NEWS & UPDATES
  • Although a stem cell transplant can be a lifesaving procedure for people diagnosed with a blood cancer or blood disorder, the standard transplant may not be appropriate for all patients. This is because the conditioning regimen (the intensive chemotherapy and/or radiation treatments preceding the transplant) is...
  • Brain tumor removal would seem to be the obvious course of action in the wake of a brain tumor diagnosis, but that’s not always the case. Some tumors are too difficult for many surgeons to reach or too close to areas that control vital functions. Removing them just proves too risky. A new device at City [...
  • Hijacking the same sorts of viruses that cause HIV and using them to reprogram immune cells to fight cancer sounds like stuff of the future. Some scientists believe that the future is closer than we think – and are now studying the approach in clinical trials at City of Hope. Immunotherapy is a promising approa...
  • Nausea is the one of the most well-known, and dreaded, side effects of cancer treatment — and with good reason. Beyond the quality-of-life issues that it causes, severe nausea can prevent patients from receiving enough nutrients and calories at a time when they need every edge they can get. A few simple actions...
  • With Labor Day just around the corner, summer is on its way out. But just because summertime is ending doesn’t mean we can skip sunscreen. Protection from ultraviolet (UV) radiation is needed all year round. Exposure to UV radiation — whether from the sun or from artificial sources such as sunlamps used i...
  • Undergoing reconstructive surgery may seem like a forgone conclusion for survivors of breast cancer, but that doesn’t appear to be the case. A new study has found that most breast cancer survivors who undergo a mastectomy decide against surgical reconstruction of their breasts. The reasons for such a deci...
  • Nearly four decades ago, City of Hope began its bone marrow transplant program. Its first transplant reunion celebration was a single patient and his donor, also his brother. This year, City of Hope welcomed hundreds of hematopoietic cell transplant (HCT) recipients to the annual bone marrow transplant/HCT reun...
  • The burgeoning type 2 diabetes epidemic casts a pall over the health of America’s public. New research now shows the looming threat is getting worse. Much worse. A diabetes trends study published earlier this month in the Lancet Diabetes and Endocrinology by researchers at the federal Centers for Disease Contro...
  • An aspirin a day might help keep breast cancer away for some breast cancer survivors, a new study suggests. Obese women who have had breast cancer could cut their risk of a recurrence in half if they regularly take aspirin or other nonsteroidal anti-inflammatory drugs, called NSAIDs, report researchers from the...
  • Christine Crews isn’t only a fitness enthusiast, she’s also a personal trainer and fitness instructor. Being active defines her life. So when she was diagnosed with bladder cancer at age 30, she decided she absolutely couldn’t let the disease interfere with that lifestyle. And it didn’t. For t...
  • Cancer treatment and the cancer itself can cause changes in your sense of taste or smell. These side effects typically subside after treatment ends, but there are ways to help alleviate those bitter and metallic tastes in your mouth. Here are tips from the National Cancer Institute to help keeps tastes and food...
  • Immunotherapy — using one’s immune system to treat a disease — has been long lauded as the “magic bullet” of cancer treatments, one that can be more effective than the conventional therapies of surgery, radiation or chemotherapy. One specific type of immunotherapy, called adoptive T cell thera...
  • Today, when cancer spreads from its original site to other parts of the body, a process known as metastasis, patients face an uphill battle. Treatments are poorly effective, and cures are nearly impossible. Further, incidence rates for these types of cancers are increasing – particularly for cancers that have s...
  • Thanks to the California Institute for Regenerative Medicine (CIRM), high school students across the state gained valuable hands-on experience with stem cell research this summer. City of Hope hosted eight of those students. As part of the CIRM Creativity Awards program, the young scholars worked full time as m...
  • Radiation therapy can help cure many children facing Hodgkin lymphoma and other cancers. When the radiation is delivered to a girl’s chest, however, it can lead to a marked increase in breast cancer risk later in life. A recent multi-institutional study that included City of Hope’s Smita Bhatia, M.D., M.P.H., t...